ArticleActive
Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
A59476
Effective: September 22, 2024
Updated: December 31, 2025
Policy Summary
This billing/coding guideline requires that the MolDX molecular biomarker test be billed using CPT 81479 with one unit of service and limits billing to one test per patient. The appropriate DEX Z-Code identifier must be entered adjacent to the CPT code in specified electronic and paper claim fields (Part B: Loop 2400/SV101-7 or Box 19; Part A: SV202-7 or UB04 Block 80), and the correct ICD-10-CM diagnosis code must be reported; do not add extra characters on the SV101-7 line.
Coverage Criteria Preview
Key requirements from the full policy
"Only one MolDX molecular biomarker test (CPT 81479) may be billed per patient."
Sign up to see full coverage criteria, indications, and limitations.